Clinical Trials Directory

Trials / Completed

CompletedNCT02641613

Retroclavicular Versus Supraclavicular Brachial Plexus Block for Hand and Forearm Surgery

The Efficacy of Retroclavicular Versus Supraclavicular Brachial Plexus Block in Patients Undergoing Forearm and Hand Surgery: a Randomized Controlled Double-blinded Trial.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Hôpital du Valais · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients will be randomized to one of two groups: 1. Supraclavicular group: supraclavicular brachial plexus block performed with the aid of ultrasound; 2. Retroclavicular group: retroclavicular brachial plexus block performed with the aid of ultrasound.

Detailed description

The study will be proposed to all patients undergoing formarm or hand surgery under brachial plexus block. Patients will be randomized to one of two groups The first group - supraclavicular group - will receive an ultrasound-guided brachial plexus block via the supraclavicular approach, by injection of 30 ml of a mixture of ropivacaine 0.5 % + mepivacaine 1 %. The second group - retroclavicular group - will receive an ultrasound-guided brachial plexus block via the retroclavicular approach, by injection of 30 ml of a mixture of ropivacaine 0.5 % + mepivacaine 1 %. Primary outcome is success rate at 30 minutes after the injection defined as loss of sensation to pinprick in the forearm and hand. Secondary outcomes are: needling time, time to first analgesic request, postoperative opioid consumption, pain scores at 12 and 24 hours postoperatively, block-related complications, and patient satisfaction.

Conditions

Interventions

TypeNameDescription
PROCEDUREretroclavicular blockretroclavicular block for forearm or hand surgery
PROCEDUREsupraclavicular blocksupraclavicular block for forearm or hand surgery

Timeline

Start date
2016-01-01
Primary completion
2018-05-01
Completion
2018-05-01
First posted
2015-12-29
Last updated
2018-05-09

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02641613. Inclusion in this directory is not an endorsement.